Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-10

Clinical Trial Update: Acute-to-chronic Glycemic Ratio (ACGR) is a Marker of DFUs .

View source ↗

Summary

A completed clinical trial suggests that the acute-to-chronic glycemic ratio (ACGR) may function as a biomarker for diabetic foot ulcers (DFU).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Diyala | Conditions: Diabetic Foot Ulcer (DFU) | Status: COMPLETED